Related Experiment Video
Updated: Sep 23, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
The correlation between promoter hypermethylation of VDR, CLDN, and CasR genes and recurrent stone formation
Fatemeh Khatami1, Alireza Gorji1, Mahdi Khoshchehreh2
1Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Objectives:
Recurrent Kidney stone formation is a main medical problem imposing a significant burden on both healthcare and the economy worldwide. Environmental and genetic factors have been linked to a bigger risk of kidney stone formation. We aim to assess the role of methylation on recurrent stone formation in three target genes.
Methods:
We aimed to check the association between promoter hypermethylation vitamin D receptor (VDR), calcium-sensing receptor (CaSR), and claudin 14 (CLDN14) genes in recurrent kidney stones. We enrolled 30 consecutive recurrent kidney stone formers (age 18-60 years) (cases) and 30 age and gender-matched controls.3. To identify promoter methylation, two target regions from each candidate gene were bisulfited after blood collection and DNA extraction. Methylation quantification was done through methylation-specific high resolution melting (MS-HRM).
Results:
The mean age of the patients and controls (mean ± SD) was 49.58 ± 14.23 years and BMI 36.12 ± 2.72. The methylation status in all six target regions was meaningfully different between the stone-former group and controls when methylation was considered in three clusters of unmethylated, methylated, and hypermethylated. A higher effect in VDR and CLDN was observed compare to CasR (p-value < 0.001, and < 0.005 versus p-value < 0.256).
Conclusions:
Methylation as an important epigenetic mechanism should be considered more in recurrent stone formations. Promoter hypermethylation of VRD and CLDN genes may have an essential role in recurrent kidney stones formations.
Insights
Epigenetic changes, specifically promoter hypermethylation in the vitamin D receptor (VDR) and claudin 14 (CLDN14) genes, are significantly associated with recurrent kidney stone formation. These findings highlight methylation
Area of Science:
- Epigenetics and Molecular Biology
- Nephrology and Urology
- Genetics and Genomics
Background:
- Recurrent kidney stone formation presents a significant global health and economic challenge.
- Environmental and genetic factors are implicated in the increased risk of developing kidney stones.
- Epigenetic mechanisms, such as DNA methylation, are increasingly recognized as potential contributors to disease pathogenesis.
Purpose of the Study:
- To investigate the association between promoter hypermethylation of the vitamin D receptor (VDR), calcium-sensing receptor (CaSR), and claudin 14 (CLDN14) genes in individuals with recurrent kidney stones.
- To assess the role of DNA methylation as an epigenetic factor in the etiology of recurrent kidney stone disease.
Main Methods:
- A case-control study involving 30 recurrent kidney stone formers (cases) and 30 age- and gender-matched controls.
- DNA was extracted from blood samples, and promoter methylation of VDR, CaSR, and CLDN14 genes was analyzed.
- Methylation quantification was performed using methylation-specific high-resolution melting (MS-HRM) analysis on bisulfite-converted DNA.
Main Results:
- Significant differences in methylation status across six target regions were observed between stone formers and controls (p < 0.001).
- Promoter hypermethylation showed a stronger association with recurrent kidney stones in the VDR and CLDN14 genes compared to the CaSR gene (p < 0.005 vs. p < 0.256).
- Methylation patterns were categorized into unmethylated, methylated, and hypermethylated clusters, revealing distinct profiles between groups.
Conclusions:
- DNA methylation is an important epigenetic mechanism that warrants consideration in the context of recurrent kidney stone formation.
- Promoter hypermethylation of the VDR and CLDN14 genes may play a crucial role in the pathogenesis of recurrent kidney stones.
- These findings suggest potential epigenetic biomarkers for identifying individuals at risk of recurrent kidney stone disease.
More Related Videos
Related Concept Videos
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Epigenetic Regulation
X-chromosome...

